We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » White House Veers from Proposals To Reduce Biologic Drug Exclusivity
White House Veers from Proposals To Reduce Biologic Drug Exclusivity
After years of pressure from lawmakers and drugmakers, the Obama administration appears to be surrendering its push for a reduced seven-year exclusivity period for biologic drugs.